156 related articles for article (PubMed ID: 32974179)
1. Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I-III Pulmonary Lymphoepithelioma-Like Carcinoma.
Li QW; Qiu B; Hu WM; Guo SP; Wu YJ; Zhu YJ; Hu N; Ai XL; Chen NB; Guo JY; Hu YH; Liu MZ; Zeng MS; Liu H
Front Oncol; 2020; 10():1487. PubMed ID: 32974179
[No Abstract] [Full Text] [Related]
2. Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients.
Xie M; Wu X; Wang F; Zhang J; Ben X; Zhang J; Li X
J Thorac Oncol; 2018 Feb; 13(2):218-227. PubMed ID: 29191777
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of circulating Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma: A meta-analysis and validation study.
Wei X; Wei Z; Zheng G; Xie T; Huo Z; Huang Y; Chen X; Bai J
J Med Virol; 2023 Jan; 95(1):e28349. PubMed ID: 36428250
[TBL] [Abstract][Full Text] [Related]
4. Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma.
Chen B; Chen X; Zhou P; Yang L; Ren J; Yang X; Li W
Respir Res; 2019 Nov; 20(1):262. PubMed ID: 31752892
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma.
Zhu L; Ouyang T; Xiong Y; Ba L; Li Q; Qiu M; Zou Z; Peng G
Front Oncol; 2021; 11():714433. PubMed ID: 34707987
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study.
Yang ZC; Du CC; Liu LT; Liang YJ; Tang LQ; Chen QY; Mai HQ; Guo SS
Adv Radiat Oncol; 2022; 7(3):100908. PubMed ID: 35647403
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
[TBL] [Abstract][Full Text] [Related]
9. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
[TBL] [Abstract][Full Text] [Related]
10. Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma-like carcinoma.
Lin CY; Chang YC; Wang IT; Hsieh MH; Wang CW; Lin SM; Wu CY; Fang YF
Oncol Lett; 2019 Dec; 18(6):6143-6149. PubMed ID: 31788088
[TBL] [Abstract][Full Text] [Related]
11. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma.
Prayongrat A; Chakkabat C; Kannarunimit D; Hansasuta P; Lertbutsayanukul C
J Radiat Res; 2017 Jul; 58(4):509-516. PubMed ID: 28204596
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
14. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
[TBL] [Abstract][Full Text] [Related]
15. Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK; Chan SY; Choi HC; Tong CC; Lam KO; Kwong DL; Vardhanabhuti V; Leung TW; Luk MY; Lee AW; Lee VH
Front Oncol; 2020; 10():1417. PubMed ID: 32974150
[No Abstract] [Full Text] [Related]
16. Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma.
Leung SF; Chan KC; Ma BB; Hui EP; Mo F; Chow KC; Leung L; Chu KW; Zee B; Lo YM; Chan AT
Ann Oncol; 2014 Jun; 25(6):1204-8. PubMed ID: 24638904
[TBL] [Abstract][Full Text] [Related]
17. Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix?
Chao A; Tsai CN; Hsueh S; Lee LY; Chen TC; Huang SL; Chao FY; Lai CH
Int J Gynecol Pathol; 2009 May; 28(3):279-85. PubMed ID: 19620947
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study.
He SS; Wang Y; Bao Y; Cai XY; Yang XL; Chen DM; Chen Y; Lu LX
Cancer Med; 2018 Apr; 7(4):1110-1117. PubMed ID: 29493874
[TBL] [Abstract][Full Text] [Related]
19. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
